SS

Sharvin Sultana Parvin

Active Director Director DIN 10822145
DIN 10822145 First appointment Oct 2024
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value β€’β€’β€’β€’ Premium profile

About Sharvin Sultana Parvin

Data last updated:

Sharvin Sultana Parvin is a Director at Jupitas Pharmaceutical Private Limited (since 2024).

DIN 10822145
Primary Designation Director
First Appointment 28 Oct 2024
Oldest Company Age 2 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director28 Oct 20242024Active

Board colleagues of Sharvin Sultana Parvin

Directorship timeline

Open interactive timeline →
Jupitas Pharmaceutical Private Limited
Premium access

Shareholding and investment profile for Sharvin Sultana Parvin

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sharvin Sultana Parvin

Sharvin Sultana Parvin currently holds 1 directorship: Jupitas Pharmaceutical Private Limited (Director, since 28 Oct 2024).

Sharvin Sultana Parvin was first appointed on 28 Oct 2024 as Director at Jupitas Pharmaceutical Private Limited.

The current boards of Sharvin Sultana Parvin's companies include Alfia Khandakar (Jupitas Pharmaceutical Private Limited), Kahinur Begum (Jupitas Pharmaceutical Private Limited), Umme Kulsum (Jupitas Pharmaceutical Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available